Trial Profile
Birth outcomes of Influenza virus vaccince (Afluria) in Pregnant Women in Lao
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Afluria) (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 13 May 2016 New trial record
- 03 May 2016 Primary endpoint (Proportion of infants born small for gestational age (SGA)) has not been met, according to the results published in the Clinical Infectious Diseases
- 03 May 2016 Primary endpoint (The mean birth weight) has not been met, according to the results published in the Clinical Infectious Diseases